Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Perioperative durvalumab and FLOT chemo can reduce risk of recurrence for some...

Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA

Perioperative durvalumab and FLOT chemo can reduce risk of recurrence for some gastric cancers ( Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA )

Nivolumab/ipilimumab followed by BRAF/MEK inhibitors preferred sequence for...

Dr Michael B. Atkins - Georgetown Lombardi Comprehensive Cancer Center...

Nivolumab/ipilimumab followed by BRAF/MEK inhibitors preferred sequence for BRAF-positive advanced melanoma ( Dr Michael B. Atkins - Georgetown Lombardi Comprehensive Cancer Center, Washington, USA )

Making immune check point inhibitors for lung cancer cost-effective in LMICs

Dr Giulia Segafredo and Dr Dario Trapani

Making immune check point inhibitors for lung cancer cost-effective in LMICs ( Dr Giulia Segafredo and Dr Dario Trapani )

Sacituzumab govitecan helps postpone progression in some PD-L1-positive triple...

Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA

Sacituzumab govitecan helps postpone progression in some PD-L1-positive triple-negative breast cancer patients ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )

BCG combined with mitomycin offers improved adjuvant treatment regimen for high...

Prof Dickon Hayne - University of Western Australia, Perth, Australia

BCG combined with mitomycin offers improved adjuvant treatment regimen for high-risk NMIBC ( Prof Dickon Hayne - University of Western Australia, Perth, Australia )

ASCO 2025: Latest in EGFR positive NSCLC

Prof Pascale Tomasini, Prof Enriqueta Felip, Prof Nicolas Girard

ASCO 2025: Latest in EGFR positive NSCLC ( Prof Pascale Tomasini, Prof Enriqueta Felip, Prof Nicolas Girard )

Characteristics associated with longer-term OS with NALIRIFOX regimen in...

Dr Vincent Chung - City of Hope, Duarte, USA

Characteristics associated with longer-term OS with NALIRIFOX regimen in metastatic pancreatic adenocarcinoma ( Dr Vincent Chung - City of Hope, Duarte, USA )

Pro-inflammatory diets associated with worse outcomes for stage III colon cancer

Dr Sara K Char - Dana-Farber Cancer Institute, Boston, USA

Pro-inflammatory diets associated with worse outcomes for stage III colon cancer ( Dr Sara K Char - Dana-Farber Cancer Institute, Boston, USA )

Exercise programme may lower risk of recurrence and death for some colon cancer...

Dr Christopher Booth - Queen's University, Kingston, Canada

Exercise programme may lower risk of recurrence and death for some colon cancer survivors ( Dr Christopher Booth - Queen's University, Kingston, Canada )

Oral paclitaxel shows non-inferior efficacy compared to IV paclitaxel for HER2...

Prof Sung-Bae Kim - Asan Medical Center, Seoul, South Korea

Oral paclitaxel shows non-inferior efficacy compared to IV paclitaxel for HER2-negative mBC ( Prof Sung-Bae Kim - Asan Medical Center, Seoul, South Korea )

Adjuvant temozolomide improves survival in IDH-mutant anaplastic glioma

Prof Martin van den Bent - Erasmus MC Cancer Institute, Rotterdam, Netherlands

Adjuvant temozolomide improves survival in IDH-mutant anaplastic glioma ( Prof Martin van den Bent - Erasmus MC Cancer Institute, Rotterdam, Netherlands )

CtDNA useful biomarker for muscle-invasive bladder cancer patients who received...

Prof Thomas Powles - Barts Cancer Institute, London, England

CtDNA useful biomarker for muscle-invasive bladder cancer patients who received perioperative durvalumab ( Prof Thomas Powles - Barts Cancer Institute, London, England )

More from ecancer